MedTrace Logo

Airtraq Versus Fiberoptic for Awake Tracheal Intubation

NCT03539185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2020-10-19

No results posted yet for this study

Summary

The airway management is a vital act in anesthesia. The gold standard technique for planned very difficult intubation is nasotracheal fiberoptic intubation. The success rate with this procedure is 98.8%. However, learning this technique is difficult and it's considered uncomfortable by patients and practitioners.

The Airtraq® videolaryngoscope is commonly used for difficult orotracheal intubation. Cases of awake intubation by Airtraq® have been described.

Furthermore, the French Society of Anesthesia-Resuscitation, in its last formalized expert recommendations (2017) on difficult intubation, proposes the use of video laryngoscopes as an alternative to the fiberoptic bronchoscope.

We propose a non-inferiority study evaluating the use of Airtraq® for the realization of a awake intubation compared to the gold standard (fiberoptic bronchoscope). This prospective randomized study should include 78 patients in two groups. The purpose of this study is to improve the comfort of patient and practitioner during an awake tracheal intubation, to facilitate the learning of the technique.

Conditions

  • Intubation;Difficult
  • Awake Intubation
  • Airway Complication of Anesthesia

Interventions

DEVICE

Videolaryngoscope Airtraq

Awake orotracheal intubation with laryngeal nerve block and remifentanil sedation

DEVICE

Fiberoptic bronchoscope

Awake nasotracheal intubation with laryngeal nerve block and remifentanil sedation

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Alexandre FRUGIER, Résident · University Hospital, Caen

  • Hervé KAMGA, Dr · University Hospital, Caen

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2020-05-18
Completion
2020-05-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03539185 on ClinicalTrials.gov